Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:2RH
Stock Latest News
Company Announcements
RedHill Biopharma Reshapes GI Portfolio With Asset Sale and New Licensing Deals
20h ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Reshapes GI Portfolio With Rebyota, Clenpiq Deal and Talicia Sale
20h ago
6K
RDHL
Premium
TipRanks Newswire
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
1M ago
RDHL
Premium
Company Announcements
RedHill Biopharma Inks 13-Year Global Deal for Ferring’s Rebyota and U.S. Rights to Clenpiq
1M ago
6K
RDHL
Premium
The Fly
RedHill acquires exclusive commercialization rights to Rebyota, Clenpiq for $12M
1M ago
RDHL
Premium
The Fly
RedHill announces acquisition of commercialization rights to Rebyota, Clenpiq
1M ago
RDHL
Premium
TipRanks Newswire
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
1M ago
RDHL
Premium
Company Announcements
RedHill Biopharma Sells Talicia Stake to Apotex for $18 Million Upfront
1M ago
6K
RDHL
Premium
The Fly
RedHill announces divestment of Talicia business to Apotex Health subsidiary
1M ago
RDHL
Premium
Company Announcements
RedHill Biopharma Shareholders Approve Leadership Changes and Share Structure Amendment
2M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Reschedules Quorum-Delayed AGM to August 7
2M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Advances Opaganib as Ebola Outbreak Worsens
2M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value
3M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market
3M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
3M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition
3M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants
3M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Sets July 28, 2026 Shareholder Meeting to Vote on Board, CEO-Chairman Role
3M ago
6K
RDHL
Premium
Company Announcements
RedHill Biopharma Secures Up to $19.4 Million in Private Placement to Fund Pipeline and Potential Acquisition
4M ago
6K
RDHL
Premium
The Fly
RedHill Biopharma announces $19.4M private placement
4M ago
RDHL
Premium
Company Announcements
RedHill Biopharma Wins FDA Rare Pediatric Disease Designation for Opaganib in Neuroblastoma
4M ago
6K
RDHL
Premium
The Fly
RedHill Biopharma’s opaganib granted FDA Rare Pediatric Disease designation
4M ago
RDHL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
